Cerity Partners LLC Apellis Pharmaceuticals, Inc. Transaction History
Cerity Partners LLC
- $44.7 Billion
- Q3 2024
A detailed history of Cerity Partners LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 31,381 shares of APLS stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,381
Previous 7,632
311.18%
Holding current value
$1.09 Million
Previous $292,000
209.93%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding APLS
# of Institutions
309Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$539 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$412 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$385 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$340 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$201 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.8B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...